Literature DB >> 21172805

TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex.

Sonja Dittmer1, Zsuzsa Kovacs, Shauna H Yuan, Gabriella Siszler, Manfred Kögl, Holger Summer, Andreas Geerts, Stefan Golz, Toshi Shioda, Axel Methner.   

Abstract

TOX3 is a nuclear protein containing a high mobility group (HMG)-box domain, which regulates Ca(2+)-dependent transcription in neurons through interaction with the cAMP-response-element-binding protein (CREB). TOX3 appears to be associated with breast cancer susceptibility and was previously shown to be expressed downstream of a cytoprotective cascade together with CITED1, a transcriptional regulator that does not bind directly to DNA. In the present study we show that TOX3 is predominantly expressed in the brain, forms homodimers and interacts with CITED1. TOX3 overexpression protects neuronal cells from cell death caused by endoplasmic reticulum stress or BAX overexpression through the induction of anti-apoptotic transcripts and repression of pro-apoptotic transcripts, which correlates with enhanced transcription involving isolated estrogen-responsive elements and estrogen-responsive promoters. However, both functions cannot be inhibited with the anti-estrogen fulvestrant and are only attenuated by mutation of estrogen-responsive elements. TOX3 also interacts with native CREB and induces the CREB-responsive BCL-2 promoter, which can be inhibited by coexpression of CITED1. Coexpression of CREB, by contrast, abolishes TOX3-mediated transcription from the estrogen-responsive complement C3 promoter. Our results suggest that TOX3 can enhance transcriptional activation from different cytoprotective promoters and that this is dependent on the predominance of either phosphorylated CREB or CITED1 within the transcriptionally active complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172805     DOI: 10.1242/jcs.068759

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

1.  Human Enhancers Are Fragile and Prone to Deactivating Mutations.

Authors:  Shan Li; Ivan Ovcharenko
Journal:  Mol Biol Evol       Date:  2015-05-14       Impact factor: 16.240

2.  Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.

Authors:  Amir Tajbakhsh; Fahimeh Afzal Javan; Mahdi Rivandi; Atefeh Moezzi; Soheila Abedini; Mahla Asghari; Zahra Farjami; Hosein Soltanian; Fatemeh Homaei Shandiz; Mohammad Mahdi Kooshyar; Alireza Pasdar
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

Review 3.  The many roles of TOX in the immune system.

Authors:  Parinaz Aliahmad; Akop Seksenyan; Jonathan Kaye
Journal:  Curr Opin Immunol       Date:  2011-12-30       Impact factor: 7.486

4.  Previous GWAS hits in relation to young-onset breast cancer.

Authors:  Min Shi; Katie M O'Brien; Dale P Sandler; Jack A Taylor; Dmitri V Zaykin; Clarice R Weinberg
Journal:  Breast Cancer Res Treat       Date:  2016-11-15       Impact factor: 4.872

5.  Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study.

Authors:  Carolyn M Hutter; Alicia M Young; Heather M Ochs-Balcom; Cara L Carty; Tao Wang; Christina T L Chen; Thomas E Rohan; Charles Kooperberg; Ulrike Peters
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-27       Impact factor: 4.254

Review 6.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

7.  Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.

Authors:  Rajesh Ramakrishnan; Hongbing Liu; Hart Donahue; Anna Malovannaya; Jun Qin; Andrew P Rice
Journal:  Retrovirology       Date:  2012-10-30       Impact factor: 4.602

8.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.

Authors:  Diana Chang; Mike A Nalls; Ingileif B Hallgrímsdóttir; Julie Hunkapiller; Marcel van der Brug; Fang Cai; Geoffrey A Kerchner; Gai Ayalon; Baris Bingol; Morgan Sheng; David Hinds; Timothy W Behrens; Andrew B Singleton; Tushar R Bhangale; Robert R Graham
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

9.  IL-1α Gene Deletion Protects Oligodendrocytes after Spinal Cord Injury through Upregulation of the Survival Factor Tox3.

Authors:  Dominic Bastien; Victor Bellver Landete; Martine Lessard; Nicolas Vallières; Mathieu Champagne; Akira Takashima; Marie-Ève Tremblay; Yannick Doyon; Steve Lacroix
Journal:  J Neurosci       Date:  2015-07-29       Impact factor: 6.167

10.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression.

Authors:  Richard Cowper-Sal lari; Xiaoyang Zhang; Jason B Wright; Swneke D Bailey; Michael D Cole; Jerome Eeckhoute; Jason H Moore; Mathieu Lupien
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.